Allergy Therapeutics plc (LON:AGY – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 7.50 ($0.09) and last traded at GBX 7.36 ($0.09), with a volume of 1111262 shares changing hands. The stock had previously closed at GBX 7.48 ($0.09).
Allergy Therapeutics Price Performance
The stock’s 50-day moving average is GBX 6.07 and its 200 day moving average is GBX 5.22. The company has a debt-to-equity ratio of 37.22, a quick ratio of 1.48 and a current ratio of 1.40. The stock has a market capitalization of £357.75 million, a PE ratio of -125.00, a P/E/G ratio of -30.70 and a beta of 1.40.
About Allergy Therapeutics
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Read More
- Five stocks we like better than Allergy Therapeutics
- What Are Dividend Contenders? Investing in Dividend Contenders
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- What Are Dividends? Buy the Best Dividend Stocks
- How Do Stock Buybacks Affect Shareholders?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
